Seer Inc.

https://www.seer.bio

LinkedIn: https://www.linkedin.com/company/seerbio

Seer, founded by Omid Farokhzad, M.D., Philip Ma, Ph.D. and Robert Langer, Sc.D., with investment from Maverick Ventures, is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. The company’s novel Proteograph™ platform allows for the first-ever generation of proteomic information with high accuracy at a scale and speed not previously possible, complementing genomic and other health information, with a goal of enabling breakthroughs in the most challenging research and clinical problems, such as early disease detection. *

	Start	2018-12-17 existent
	Industry	Proteograph™ platform (Seer Inc)
	Industry 2	molecular diagnostics
	Person	Ma, Philip (PrognomiQ 202009– CEO + Founder before Seer 201812 CBO + Co-Founder before Biogen + McKinsey)

	Region	Redwood City, CA
	Country	United States (USA)
	Street	3800 Bridge Parkway Suite 102
	City	94065 Redwood City, CA
	Tel	+1-650-453-0000
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Seer, Inc.. (12/17/19). "Press Release: Seer Announces $55 Million in Series D Equity Financing. Bringing in New Investors aMoon Fund and T. Rowe Price Funds". Redwood City, CA.

		Record changed: 2023-07-10